**Patient Discharge Summary**

**Patient Information:**

* Name: John Doe
* Age: 35
* Sex: Male
* Admission Date: March 10, 2023
* Discharge Date: March 17, 2023

**Chief Complaint:**

John Doe presented to the emergency department on March 10, 2023, with a 3-day history of fever, cough, and fatigue. He reported worsening symptoms over the past 24 hours, including chest tightness and difficulty breathing.

**Physical Examination:**

On admission, John's temperature was 102.5°F (39.1°C), blood pressure 120/80 mmHg, pulse 110 beats per minute, and oxygen saturation 92% on room air. He had a productive cough, and his lungs were clear to auscultation. His chest x-ray revealed bilateral interstitial infiltrates consistent with primary influenza pneumonia.

**Laboratory Results:**

* Complete Blood Count (CBC): Normal white blood cell count, with mild lymphopenia
* Blood Chemistry: Normal electrolytes, renal function, and liver enzymes
* Rapid Antigen Test (RAT): Positive for influenza A
* Reverse Transcription Polymerase Chain Reaction (RT-PCR): Positive for influenza A (H3N2) subtype
* Blood Cultures: Negative

**Diagnostic Workup:**

In addition to the above laboratory results, John underwent a thorough physical examination, including a thorough respiratory examination, and a chest x-ray to rule out other causes of pneumonia. A nasal swab was collected for RT-PCR testing, which confirmed the presence of influenza A (H3N2) subtype.

**Treatment:**

John was diagnosed with influenza A (H3N2) pneumonia and treated with antiviral therapy. He was prescribed Oseltamivir 75 mg orally twice a day, starting on March 11, 2023. He also received hydration therapy with normal saline solution, antipyretics (acetaminophen 325 mg every 4 hours), and rest.

**Hospital Course:**

John's condition improved gradually over the next few days, with resolution of his fever and cough. His oxygen saturation remained stable, and his chest x-ray showed gradual clearing of the infiltrates. He was discharged on March 17, 2023, with continued treatment at home.

**Medications:**

* Oseltamivir 75 mg orally twice a day (starting March 11, 2023)
* Hydration therapy with normal saline solution
* Antipyretics (acetaminophen 325 mg every 4 hours)
* Rest and hydration at home

**Discharge Instructions:**

John was instructed to continue taking Oseltamivir as directed, to rest and avoid strenuous activities, and to drink plenty of fluids to prevent dehydration. He was also advised to follow up with his primary care physician in 1 week to monitor for any signs of complications or relapse.

**Follow-up:**

John is scheduled for a follow-up appointment with his primary care physician on March 24, 2023, to monitor his progress and rule out any complications.

**Conclusion:**

John Doe was diagnosed with influenza A (H3N2) pneumonia and treated with antiviral therapy. His condition improved gradually over the next few days, and he was discharged on March 17, 2023, with continued treatment at home. He was advised to follow up with his primary care physician in 1 week to monitor for any signs of complications or relapse.